Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial

Havel, L., Kolek, V., Pešek, M., Černovská, M., Bartůňková, J., Spíšek, R., Pecen, L., Krasnopolskaya, I., Zemanová, M. Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial. Journal of Clinical Oncology. 2019, 37(suppl), 9039-9039. ISSN 0732-183X. E-ISSN 1527-7755. Dostupné z: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.9039